Fineline Cube

Follow:
14422 Articles
China Unveils “Healthcare Foundation Strengthening Plan” to Bring Clinics Within 15‑Minute Reach
Policy / Regulatory

China Unveils “Healthcare Foundation Strengthening Plan” to Bring Clinics Within 15‑Minute Reach

TransThera Sciences Secures China Phase II Trial Approval for Tinengotinib‑Fulvestrant Combination
CompanyDrug

TransThera Sciences Secures China Phase II Trial Approval for Tinengotinib‑Fulvestrant Combination

Innovent Biologics & Cowell Health Forge Strategic Alliance to Boost Drug Access
CompanyDeals

Innovent Biologics & Cowell Health Forge Strategic Alliance to Boost Drug Access

Taiji Group Secures NMPA Approval to Begin Clinical Trials of Semaglutide Biosimilar
CompanyDrug

Taiji Group Secures NMPA Approval to Begin Clinical Trials of Semaglutide Biosimilar

Betta Pharmaceuticals Secures NMPA Approval for MCLA‑129/Ensartinib Combination in Advanced Solid Tumors
CompanyDrug

Betta Pharmaceuticals Secures NMPA Approval for MCLA‑129/Ensartinib Combination in Advanced Solid Tumors

Qilu Pharmaceutical & FDSTC Announce Strategic Partnership to Boost China’s Biomedical Innovation
CompanyDeals

Qilu Pharmaceutical & FDSTC Announce Strategic Partnership to Boost China’s Biomedical Innovation

Corxel and WuXi Forge Cardiovascular Partnership to Accelerate Drug Development
CompanyDeals

Corxel and WuXi Forge Cardiovascular Partnership to Accelerate Drug Development

Danaher Partners with Beckman to Advance Alzheimer’s Blood‑Biomarker Diagnosis
CompanyDeals

Danaher Partners with Beckman to Advance Alzheimer’s Blood‑Biomarker Diagnosis

Johnson & Johnson Secures FDA Approval for INLEXZO, a Ground‑breaking Intravesical System for Bladder Cancer
CompanyDrug

Johnson & Johnson Secures FDA Approval for INLEXZO, a Ground‑breaking Intravesical System for Bladder Cancer

China’s 11th National Centralized Drug Procurement Draft Unveils Major Pricing & Competition Reforms
Others

China’s 11th National Drug VBP Draft Unveils Major Pricing & Competition Reforms

Kexing Biopharm Secures Global Rights to Humanwell PuraCap’s Nintedanib
CompanyDeals

Kexing Biopharm Secures Global Rights to Humanwell PuraCap’s Nintedanib

Novo Nordisk Launches Company‑Wide Transformation to Drive Diabetes and Obesity Growth
Company

Novo Nordisk Launches Company‑Wide Transformation to Drive Diabetes and Obesity Growth